In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

Modifiable risk factors such as self-efficacy, sleep disturbances, and pain severity were associated with disability risk among patients with chronic LBP.